• All Rooms
• Room 1
• Room 2
• Room 3
• Room 4
• Room 1+2

March 29 (Saturday)

[YI] Young Investigator Award Presentation Room 1

• March 29 (Sat), 08:00-09:00
• Myung-Hyun Nam (Korea University College of Medicine, Korea)
  Dok Hyun Yoon (University of Ulsan College of Medicine, Korea)
• 08:00-08:07 Evaluation of the clinical applicability of assessing treatment response and minimal residual disease in acute myeloid leukemia through total RNA sequencing of peripheral blood circulating exosomes Kunye Kwak (Korea University Anam Hospital, Korea) 08:07-08:14 Serial gene mutation analyses in patients with relapse or refractory acute lymphoblastic leukemia using whole genome sequencing Kyoung Il Min (College of Medicine, The Catholic University of Korea, Korea) 08:14-08:21 Developing a prospective cohort study for an at-risk population with germline predisposing mutations for hematologic malignancies Silvia Park (College of Medicine, The Catholic University of Korea, Korea) 08:21-08:28 Study on changes in bone marrow adipocyte metabolites in acute leukemia patients undergoing chemotherapy Young Hoon Park (Ewha Womans University College of Medicine, Korea) 08:28-08:35 Introduction of chimeric antigen receptor into natural-killer cells by high efficiency electroporation based mRNA delivery system Jae-Ho Yoon (College of Medicine, The Catholic University of Korea, Korea) 08:35-08:42 Whole-exome sequencing-based analysis of treatment response and clonal evolution in patients with chronic lymphocytic leukemia Ho Cheol Jang (Chonnam National University Hwasun Hospital, Korea) 08:42-08:49 A study on early detection of neurotoxicity in pediatric leukemia patients through CSF biomarker analysis Seung Min Hahn (Yonsei University College of Medicine, Korea) 08:49-08:56 Identification of CNS relapse biomarkers using cerebrospinal fluid cell-free DNA analysis: A phase 1 study of pomalidomide + R-CHOP in high-risk diffuse large B-cell lymphoma patients with risk of CNS relapse Jae Won Hyung (Asan Medical Center, Korea)

[JS05] Joint Session 05 (Asia Session): MRD and Immunotherapy in Multiple Myeloma: Collaborative Insights from Korea and Japan Room 1

• March 29 (Sat), 09:00-10:15
• Jin Seok Kim (Yonsei University College of Medicine, Korea)
  Hiroyuki Takamatsu (Kanazawa University, Japan)
• 09:00-09:15 Current status of MRD assessment in Japan Hiroyuki Takamatsu (Kanazawa University, Japan) 09:15-09:30 Current status of MRD assessment in Korea Saeam Shin (Yonsei University College of Medicine, Korea) 09:30-09:45 Advances in the treatment for RRMM using CAR-T and bispecific antibodies Tadao Ishida (Japanese Red Cross Medical Center, Japan) 09:45-10:00 Real-world efficacy and safety of teclistamab for patients with released or refractory multiple myeloma: Korean, nationwide, retrospective analysis Jun Ho Yi (Chung-Ang University College of Medicine, Korea) 10:00-10:15 Discussion

[SS14] Scientific Session 14: Deciphering Blood Coagulation Tests Room 2

• March 29 (Sat), 09:00-10:15
• Jeong Yeal Ahn (Gachon University College of Medicine, Korea)
  Hyun Kyung Kim (Seoul National University College of Medicine, Korea)
• 09:00-09:25 Investigative approaches to unexplained bleeding Alessandro Casini (University Hospitals of Geneva, Switzerland) 09:25-09:50 Optimal testing strategies for suspected platelet disorders Christopher Ward (University of Sydney, Australia) 09:50-10:15 Thrombophilia testing in clinical practice: Indications, challenges, and current approaches Hee-Jin Kim (Sungkyunkwan University School of Medicine, Korea)

[SS15] Scientific Session 15: Immunotherapy in B-Cell Lymphoma: Current Status and Emerging Approaches Room 3

• March 29 (Sat), 09:00-10:15
• Gyeong-Won Lee (Gyeongsang National University College of Medicine, Korea)
  Yoon Seok Choi (Korea University College of Medicine, Korea)
• 09:00-09:25 Advancing CD3xCD20 bispecific Abs: Integration in first-line treatment of DLBCL  Catherine Thieblemont (Hôpital Saint-Louis, France) 09:25-09:50 Antibody based treatments for B-cell Lymphoma: New targets and future directions Youngil Koh (Seoul National University College of Medicine, Korea) 09:50-10:15 Management of toxicity of bispecific antibody for B-cell lymphomas Koji Izutsu (National Cancer Center Hospital, Japan)

[ES08] Education Session 08: Supportive Care: Management of Infections and Iron Overload KOR Room 4

• March 29 (Sat), 09:00-10:15
• Byong Soo Kim (Korea University College of Medicine, Korea)
  Yeung-Chul Mun (Ewha Womans University College of Medicine, Korea)
• 09:00-09:25 Invasive fungal infections in hematologic disease: Prophylaxis and treatment Sung-Yeon Cho (College of Medicine, The Catholic University of Korea, Korea) 09:25-09:50 CMV infections after HSCT: Prophylaxis and treatment Haerim Chung (Yonsei University College of Medicine, Korea) 09:50-10:15 Iron overload and iron chelation therapy Ga-Young Song (Chonnam National University Medical School, Korea)

[PL03] Plenary Lecture 03 Room 1+2

• March 29 (Sat), 10:30-11:15
• Dong-Wook Kim (Eulji University School of Medicine, Korea)
• 10:30-11:15 New discoveries that will shape future therapies in Chronic Myeloid Leukemia Timothy Hughes (South Australian Health and Medical Research Institute (SAHMRI), Australia)